Losses
-€9,010 in two years
The 2024 and 2025 financial years closed with a loss. 2024 was the heaviest.
ImmoDerm
Overview
Lifetime
4 annual accounts with figures on one time axispeak €34,160 (2022)
€31,496▲ 21.0%
lowest -€6,942 (2024)
-€2,067▲ €4,875
peak €39,778 (2023)
€30,768▼ 6.3%
€507,226▼ 3.1%
Board1 name since 2021
1 directorSara Nguyen
Documentsfilings and deeds
24-08-202624 days late
2025micro format
Gross margin from €26,020 to €31,496Loss of €2,067Cash from €5,063 to €7,678
Key points
from the 2025 annual accountsChecked score
81
Excellent
Financially stronger than 36% of micro companies in real estate (NACE 68)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.5% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.2% across 26,625 companies (NACE 68, micro).
About 5 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.3%lowest value
01-2025: 0.3%● unchanged vs 12-2024lowest value
02-2025: 0.3%● unchanged vs 01-2025
03-2025: 0.3%● unchanged vs 02-2025
04-2025: 0.3%● unchanged vs 03-2025
05-2025: 0.3%● unchanged vs 04-2025
06-2025: 0.4%▲ +0.1 percentage points vs 05-2025
07-2025: 0.4%● unchanged vs 06-2025
08-2025: 0.5%▲ +0.1 percentage points vs 07-2025
09-2025: 0.7%▲ +0.2 percentage points vs 08-2025
10-2025: 0.5%▼ -0.2 percentage points vs 09-2025
11-2025: 0.5%● unchanged vs 10-2025
12-2025: 0.5%● unchanged vs 11-2025
01-2026: 0.5%● unchanged vs 12-2025
02-2026: 0.5%● unchanged vs 01-2026
03-2026: 0.5%● unchanged vs 02-2026
04-2026: 0.5%● unchanged vs 03-2026
05-2026: 0.6%▲ +0.1 percentage points vs 04-2026
06-2026: 0.6%● unchanged vs 05-2026
07-2026: 0.6%● unchanged vs 06-2026
08-2026: 1.0%▲ +0.4 percentage points vs 07-2026highest value
09-2026: 0.5%▼ -0.5 percentage points vs 08-2026
10-2026: 0.5%● unchanged vs 09-2026
11-2026: 0.5%● unchanged vs 10-2026
Financial strengthWeak
Score breakdown
raises risk
Last filed accounts filed 24 days late; 1 of the last 3 accounts late
Liquidity: current ratio 0.07, cash €7,678
lowers risk
Sector: Real estate activities (NACE 68)
Size: total assets €537,994
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 68, micro). It does better than 27% of them on solvency, 40% on liquidity, 45% on profitability and 32% on growth.
The bankruptcy probability was computed on 08-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 865 companies had the same profile as ImmoDerm has now. Each dot stands for 3 companies, two years later.
96.6%
were still trading
1.7%
stopped another way
1.5%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of ImmoDerm itself: 0.5% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 865 companies, not a prediction for ImmoDerm. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €2,000 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.07 (0.07 in 2024), below 1. Short-term debt is 20.6% and cash 1.4% of total assets. 94.3% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises risk
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
22232425
2022 to 2025 · latest year -€2,067
raises risk · 2025 accounts filed 24 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-08-2026, 24 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 4 filingsDeviation from the deadline
2025
24 days late
2024
35 days late
2023
26 days late
2022
28 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 4 accounts on average 28 days after the deadline. In the sector (NACE 68), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 August (4 of the last 4 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
09-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0778688086
Incorporation
Founding capital of €2,500, 100 shares · Founder: NGUYEN Sara Hoang Anh (partner and founder) · Appointment: NGUYEN Sara Hoang Anh (director) · published on 20-12-2021 · Gazette deed
First establishment
Poverstraat 74, Dilbeek
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| ImmoDerm Dilbeek | €537,994 | €31,496 | 5.7% | - |
| Ateliers Minnoye Leuven | €619,145 | €35,239 | -0.6% | - |
| TRIGIMMO Leuven | €475,414 | €34,427 | 35.0% | - |
| VILLA FL Overijse | €428,118 | €31,903 | -1.0% | - |
| MAISON G Waregem | €496,644 | €32,503 | 17.7% | - |
| ELIFRAUR Arlon | €491,879 | €32,028 | 27.4% | - |
| RD PROJECTS Anzegem | €541,845 | €36,324 | 2.2% | - |
These companies have the same main activity as ImmoDerm: renting and operating of own or leased non-residential real estate, excluding land (NACE 68203). They are comparable in size and age: total assets between €428,000 and €619,000, founded between 2021 and 2022.
Official details
Source: KBO- Status
- Active since 15-12-2021Normal situation
- Activity
- Renting and operating of own or leased non-residential real estate, excluding landNACE 68203
- Establishment unit
- 2.325.122.5631700 Dilbeek, since 15-12-2021
- Financial year end
- 31 December
- Peppol
- Reachable since 13-06-2025
Annual accounts 2025
- €31,496▲ 21.0%
- ≈ €51,000estimated
- €2,067▼ 70.2%
- €30,768▼ 6.3%
- €537,994▼ 3.3%
- Filing
- Filed on 24-08-2026
Insights on ImmoDerm
ImmoDerm files the micro format. That format states no turnover. The gross margin fell from €34,160 in 2022 to €31,496 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2025
micro format, filed on 24-08-2026, 24 days late€31,496
▲ 21.0%
€4,804
▲ 862%
-€2,067
▲ €4,875
-€103,118
▼ €13,862
5.7%
▼ 0.2 percentage points
0.07
▼ 0.00
Turnover and EBIT margin are not published. The abbreviated or micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €51,000. Estimated: probably between €38,000 and €75,000.
Balance sheet
balance sheet total €537,994 on 31-12-2025What the company ownsHow it is paid for
in euro
in euro
Position in the sector
5.7%
Higher than 28% of 17,190 companies in 2025.
0.07
Higher than 9% of 16,487 companies in 2025.
-0.4%
Higher than 34% of 16,866 companies in 2025.
ImmoDerm
Middle half of the sector
80% of the sector
Micro accounts in real estate (NACE 68)
Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: bottom quarter
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Balance sheet: assets | |||||
20/58 |
537,994 | 556,230 | 567,196 | 555,517 | |
20 |
213 | 436 | 659 | 882 | |
21/28 |
529,953 | 548,935 | 546,021 | 515,021 | |
22/27 |
529,953 | 548,935 | 546,021 | 515,021 | |
22 |
518,293 | 531,561 | 528,083 | 497,156 | |
23 |
9,601 | 13,953 | 12,873 | 12,753 | |
24 |
2,060 | 3,421 | 5,065 | 5,111 | |
29/58 |
7,828 | 6,859 | 20,515 | 39,614 | |
40/41 |
- | 1,646 | 155 | 18,257 | |
40 |
- | 1,646 | - | 18,000 | |
41 |
- | - | 155 | 257 | |
54/58 |
7,678 | 5,063 | 20,360 | 21,357 | |
490/1 |
150 | 150 | - | - | |
| Balance sheet: equity and liabilities | |||||
10/49 |
537,994 | 556,230 | 567,196 | 555,517 | |
10/15 |
30,768 | 32,835 | 39,778 | 28,033 | |
10/11 |
2,500 | 2,500 | 2,500 | 2,500 | |
13 |
28,268 | 30,335 | 37,278 | 25,533 | |
133 |
28,268 | 30,335 | 37,278 | 25,533 | |
17/49 |
507,226 | 523,395 | 527,418 | 527,485 | |
17 |
396,280 | 425,635 | 444,427 | 485,291 | |
170/4 |
396,280 | 425,635 | 444,427 | 485,291 | |
42/48 |
110,946 | 96,115 | 82,991 | 42,193 | |
42 |
41,628 | 41,043 | 40,468 | 37,719 | |
44 |
- | 898 | 1,326 | 2,206 | |
440/4 |
- | 898 | 1,326 | 2,206 | |
46 |
6,437 | - | - | - | |
45 |
632 | 2,016 | 8,929 | - | |
450/3 |
632 | 2,016 | 8,929 | - | |
47/48 |
62,249 | 52,158 | 32,268 | 2,268 | |
492/3 |
- | 1,646 | - | - | |
| Income statement | |||||
9900 |
31,496 | 26,020 | 23,906 | 34,160 | |
630 |
24,705 | 23,608 | 5,026 | 1,479 | |
640/8 |
1,986 | 1,912 | - | - | |
9901 |
4,804 | 499 | 18,880 | 32,681 | |
75/76B |
0 | - | 20 | 0 | |
75 |
0 | - | 20 | 0 | |
65/66B |
6,872 | 7,442 | 7,156 | 7,149 | |
65 |
6,872 | 7,442 | 7,156 | 7,149 | |
9903 |
-2,067 | -6,942 | 11,745 | 25,533 | |
9904 |
-2,067 | -6,942 | 11,745 | 25,533 | |
9905 |
-2,067 | -6,942 | 11,745 | 25,533 | |
| Appropriation of the result | |||||
9906 |
-2,067 | -6,942 | 11,745 | 25,533 | |
791/2 |
2,067 | 6,942 | - | - | |
691/2 |
- | - | 11,745 | 25,533 | |
6921 |
- | - | 11,745 | 25,533 | |
| Document | |||||
The notes to these accounts have 7 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 24-08-2026.
Filings
each dot is a set of accounts, on the day it reached the National Bank2025 annual accounts filed 24 days after the deadline. Filed on 24 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00416100.
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| 29,509 | 24,108 | 23,906 | 34,160 | ||
| 22,638 | 16,666 | 16,771 | 27,012 | ||
| 5,500 | 26,299 | 35,803 | 516,266 | ||
| 2,614 | -15,297 | -997 | - | ||
| -103,118 | -89,256 | -62,476 | -2,579 | ||
| 5.7% | 5.9% | 7.0% | 5.0% | ||
| 0.07 | 0.07 | 0.25 | 0.94 | ||
| 16.49 | 15.94 | 13.26 | 18.82 | ||
| -6.7% | -21.1% | 29.5% | 91.1% | ||
| -0.4% | -1.2% | 2.1% | 4.6% | ||
| 4.29 | 3.24 | 3.34 | 4.78 |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Tangible fixed assets | €5,500 | €26,299 | €35,803 | €516,266 |
| €24,705 | €23,608 | €5,026 | €1,479 |
Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)
Insights on ImmoDerm
The operating result for 2025 is 9.6 times that of 2024. It is a recovery after the fall in 2024.
Debt's share of the balance-sheet total rises from 94.1% to 94.3%. Equity and debt are lower.
Board & ownership
Board
1 director, since incorporationDirector (not named in the articles)
appointed by deed of 20-12-2021
term without a fixed end
listed in the 2025 annual accounts, filed on 24-08-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 20-12-2021
Mandates through the years
1 name, the dashed line is todaySara Nguyen
Director (not named in the articles)
Director (not named in the articles)
Board
Mandates as a list
- Sara Nguyen
- Director (not named in the articles), from 15-12-2021 to date
Control
Capital
- Contribution
- €2,500
- Shares
- 100
- Contribution per share
- €25
- Equity per share
- €308 in 2025
- Source
- deed of 20-12-2021
Articles of association
deed of 20-12-2021 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Friday of June at 18:00
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
Shareholders
At incorporation
deed of 20-12-2021 ↗
- NGUYEN Sara Hoang Anh 100 shares (100%) · €2,500 in cash
Network & group
No group
ImmoDerm has no parent and no holdings in its annual accounts. Sara Nguyen is the only director.
At the same address
Poverstraat 74, 1700 Dilbeek · 1 other company| Dr. Sara Nguyen Dermatoloog
registered office since 29-11-2019 · founded in 2019 |
total assets €237,709 (2025) 0738.594.622 |
Earlier ties
| Dr. Sara Nguyen Dermatoloog via Sara Nguyen, no longer at Dr. Sara Nguyen Dermatoloog · Director (not named in the articles) · deed of 03-12-2019 founded in 2019 |
total assets €237,709 (2025) |
| DERMAHUIS via Sara Nguyen, no longer at DERMAHUIS · Manager · deed of 12-01-2022 No longer active |
Connections & network
The network starts from the earlier ties.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Timeline
Timeline
8 events since 2021Filings
Financial
Establishments
202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 24 days late
2025
Annual accounts 2024 filed PDFmicro format · 35 days late
Registered in the Peppol Directory Reachable for e-invoices through 0208:0778688086
2024
Weakest financial year net -€6,942 The net result drops to -€6,942, the lowest from 2022 to 2025. It recovers the following year.
Annual accounts 2023 filed PDFmicro format · 26 days late
2023
Annual accounts 2022 filed PDFabbreviated format · 28 days late
2021
IncorporationFounding capital of €2,500, 100 shares · Founder: NGUYEN Sara Hoang Anh (partner and founder) · Appointment: NGUYEN Sara Hoang Anh (director) · published on 20-12-20215 points ▸
- Founder, NGUYEN Sara Hoang Anh (partner and founder)
- Founding capital, €2,500, 100 shares
- Registered office clause, Poverstraat 74, 1700 Sint-Martens-Bodegem
- Board rule, 1
- Director appointment, NGUYEN Sara Hoang Anh (director (not named in the articles))
- The deed holds 1 more point.
First establishment Poverstraat 74, Dilbeek
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
On 15 December 2021, ImmoDerm was incorporated as a private limited company by one natural person, with a starting capital of €2,500.12 Sara Nguyen is director of the company, appointed by deed of 20-12-2021.2 Total assets went from €555,517 in 2022 to €537,994 in 2025.3
Company details
Identity
- Enterprise number
- 0778.688.086
- VAT number
- BE 0778.688.086
- Peppol ID
- 0208:0778688086
- Other Peppol ID
- 9925:BE0778688086
- Legal form
- Private limited company
- Status
- Active, normal situation
- Founded
- 15-12-2021
- Financial year
- ends on 31 December
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Friday of June at 18:00deed of 20-12-2021 (in Dutch)
- Peppol
- Reachable since 13-06-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
- Name
- ImmoDerm in Dutch
- Entity type
- Legal entity
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 20-12-2021 (in Dutch)
- Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
- “Vlaams Gewest”deed of 20-12-2021 (in Dutch)
Activities
NACEBEL 202568203
Renting and operating of own or leased non-residential real estate, excluding land main activity
Codes under NACEBEL 2008
68203
Real estate rental main activity
- PurposeThe purpose describes the activities the company may carry out under its articles.
- “Beheer,verhuur en exploitatie van eigen of geleasde onroerende en roerende goederen; De vennootschap kan dus…”deed of 20-12-2021 (in Dutch)
4 activities
- Beheer,verhuur en exploitatie van eigen of geleasde onroerende en roerende goederen.
- De vennootschap kan dus verkopen,verwerven,ruilen,omvormen,huren,uitbaten,afstaan,andere zakelijke rechten aangaan of toestaan en bouwen van alle onroerende goederen en alle onroerende activiteiten realiseren,maar uitsluitend voor zover deze rechtstreeks of onrechtstreeks verband houden met de verwezenlijking van haar maatschappelijk doel.Het is haar dus verboden handelingen als vastgoedmakelaar te stellen.
- De mogelijkheid tot het aanschaffen van gemeenschappelijk personeel ( secretaresse,kuispersoneel,assistent,... ).
- Het waarnemen van bestuursopdrachten en mandaten,het uitoefenen van opdrachten en functies,het optreden als vereffenaar.
Registered office and establishments
1 establishment| Establishment | Since | Unit number |
|---|---|---|
| Poverstraat 74 registered office 1700 Dilbeek | 15-12-2021 | 2.325.122.563 |
Buildings and parcels at the address
- Ground area
- 1,002 m²
- Buildings
- 137 m²
- Volume, LiDAR
- 3 m³
- Tallest building
- 0.2 m
Buildings to scale, each on its own parcel
Parcels
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 23074C0382/00P000 | 1,002 m² | 1 · 137 m² | 0.2 m |